Zdrowie i gospodarka · 16/11/2022
FDA Requests Comments on Naloxone for Nonprescription Use
The Food and Drug Administration (FDA) is seeking public input on its preliminary assessment that certain naloxone products may be approvable for nonprescription use, potentially eliminating the need for a prescription requirement to protect public health.
Source: Federal Register — Food and Drug AdministrationOpen original release →